Paritaprevir/ritonavir/ombitasvir+dasabuvir plus ribavirin therapy and inhibition of the anticoagulant effect of warfarin: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paritaprevir/ritonavir/ombitasvir+dasabuvir plus ribavirin therapy and inhibition of the anticoagulant effect of warfarin: a case report

Published:2016-11-03 Issue:1 Volume:42 Page:115-118
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Puglisi G. M.¹^ORCID,Smith S. M.²,Jankovich R. D.³,Ashby C. R.⁴,Jodlowski T. Z.⁵

Affiliation:

1. PGY2 Pharmacy Resident, Ambulatory Care; VA Maine Healthcare System; Augusta ME USA

2. Clinical Pharmacy Specialist; Pharmacy Service; VA Maine Healthcare System; Augusta ME USA

3. Gastroenterology Section, Medical Service; VA Maine Healthcare System; Augusta ME USA

4. Department of Pharmaceutical Sciences; St. John's University; Queens NY USA

5. Clinical Pharmacy Specialist; Pharmacy Service; VA North Texas Health Care System; Dallas TX USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12475/fullpdf

Reference27 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010;Denniston;Ann Intern Med,2014

3. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008;Denniston;Hepatology,2012

4. Natural history of hepatitis C;Westbrook;J Hepatol,2014

5. Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?;Schmidt;BMC Public Health,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Available Agents: Contraindications and Potential Drug–Drug Interactions;Hepatitis C: Care and Treatment;2021

2. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties;Journal of Clinical Medicine;2020-06-02

3. Decreased warfarin sensitivity among patients treated with elbasvir and grazoprevir for hepatitis C infection;American Journal of Health-System Pharmacy;2019-08-16

4. Dynamics and management of oral anticoagulant treatment in chronic hepatitis C patients undergoing therapy with direct antiviral agents;Journal of Chemotherapy;2019-02-17

5. Inductive Effect of a Ritonavir-Containing Hepatitis C Treatment Regimen on Warfarin in a Patient—A Case Report;Journal of Pharmacy Practice;2018-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3